BSI PD ISO/TS 16550:2014
$142.49
Nanotechnologies. Determination of silver nanoparticles potency by release of muramic acid from Staphylococcus aureus
| Published By | Publication Date | Number of Pages |
| BSI | 2014 | 24 |
This Technical Specification provides a test method for evaluating potency of silver nanoparticles to cell wall degradation of Staphylococcus aureus and muramic acid release as quantified by a gas chromatography-mass spectrometry (GC-MS).
PDF Catalog
| PDF Pages | PDF Title |
|---|---|
| 6 | Foreword |
| 7 | Introduction |
| 8 | Section sec_1 Section sec_2 Section sec_2.1 Section sec_2.2 Section sec_2.3 Section sec_2.4 Section sec_2.5 Section sec_2.6 1 Scope 2 Terms and definitions |
| 9 | Section sec_2.7 Section sec_2.8 Section sec_2.9 Figure fig_1 Section sec_2.10 Section sec_2.11 |
| 10 | Section sec_2.12 Section sec_2.13 Section sec_2.14 Section sec_2.15 Section sec_2.16 Section sec_3 Section sec_4 3 Symbols and abbreviated terms 4 Principles |
| 11 | Section sec_5 Section sec_5.1 Section sec_5.1.1 Section sec_5.1.2 Section sec_5.1.2.1 Section sec_5.1.2.2 5 Sample preparation for the determination of MA 5.1 Bacterial growth and AgNP treatment |
| 12 | Section sec_5.1.2.3 Section sec_5.1.2.4 Section sec_5.1.2.5 Section sec_5.1.2.6 Table tab_1 |
| 13 | Section sec_5.1.2.7 Section sec_5.2 Section sec_5.3 Section sec_5.4 5.2 Hydrolysis of cell wall 5.3 Derivatization of cell wall 5.4 Gas chromatography-mass spectrometry instrumentation |
| 14 | Figure fig_2 Section sec_6 Table tab_2 6 Data analysis and results interpretations |
| 15 | Section sec_7 7 The test method for silver nanoparticle sample |
| 16 | Annex sec_A Annex A (informative) Gas chromatography-mass spectrometry |
| 17 | Annex sec_B Annex B (informative) Internal standard |
| 18 | Annex sec_C Annex C (informative) Preparation of laboratory-prepared silver nanoparticles reference materials |
| 19 | Annex sec_D Table tab_D.1 Annex D (informative) Silver nanoparticle suspension preparation |
| 20 | Annex sec_E Annex E (informative) Treatment control conditions; positive, negative, and bacterial suitability controls |
| 21 | Reference ref_1 Reference ref_2 Reference ref_3 Reference ref_4 Reference ref_5 Reference ref_6 Reference ref_7 Reference ref_8 Reference ref_9 Reference ref_10 Reference ref_11 Reference ref_12 Reference ref_13 Reference ref_14 Reference ref_15 Reference ref_16 Reference ref_17 Reference ref_18 Reference ref_19 Bibliography |
| 22 | Reference ref_20 |
